Good news

Fushine Pharmaceuticals' wholly-owned subsidiary Fushine Technology

A new national invention patent

Recently, an invention patent for "A method for effectively removing the odor of ascomycin fermentation tail gas" by Fushine Technology, a wholly-owned subsidiary of Fushine Pharmaceuticals, successfully passed the review of the State Intellectual Property Office and successfully obtained an invention patent certificate.

Patent Introduction

In recent years, the company has actively expanded into synthetic biology to empower its pharmaceutical business and has also expanded into the microbial protein business. The company has developed a technology that effectively removes the odor from ascomycin fermentation exhaust. This technology effectively removes odorous substances from ascomycin fermentation exhaust, providing technical support for fermentation exhaust treatment. This patented technology has already achieved positive results in the company's actual production.

The acquisition of this patent is in line with the company's development strategy plan, which will help further promote the company's development in the field of synthetic biology, improve the company's intellectual property system, and enhance the company's core competitiveness.